Alphatec Holdings ATEC
NASDAQ ATEC
$9.47 -0.28 (-2.92%)
At close: Aug 20, 2026 · 12:14 PM UTC

Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025)

Alphatec Holdings (ATEC) posted Non-Current Deffered Revenue of $2.2 million for Q4 2025, down 30.37% sequentially from $3.1 million in Q4 2024, and down 30.37% YoY from $3.1 million in Q4 2024.

Alphatec Holdings (ATEC) Non-Current Deffered Revenue (2021 - 2025) Analysis & Trends

Alphatec Holdings has reported Non-Current Deffered Revenue for 5 years, with the latest figure at $2.2 million in Q4 2025.

  • Quarterly Non-Current Deffered Revenue fell 30.37% year-over-year to $2.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $2.2 million (down 30.37% YoY) and the FY2025 annual result came in at $2.2 million, down 30.37% from the prior year.
  • Non-Current Deffered Revenue slipped to $2.2 million in Q4 2025 per ATEC's latest filing, from $3.1 million in the prior quarter.
  • Over five years, Non-Current Deffered Revenue peaked at $3.1 million in Q4 2024 and troughed at $2.2 million in Q4 2025.
  • A 5-year average of $2.8 million and a median of $2.8 million in 2021 frame the typical range for Non-Current Deffered Revenue.
  • The sharpest annual moves came in 2024 and 2025: Non-Current Deffered Revenue gained 20.42% in 2024, then plunged 30.37% in 2025.
  • Over 5 years, Non-Current Deffered Revenue stood at $2.9 million in 2021, then grew by 3.45% to $3.0 million in 2022, then declined by 13.33% to $2.6 million in 2023, then gained by 20.42% to $3.1 million in 2024, then slumped by 30.37% to $2.2 million in 2025.
  • According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $2.2 million, $3.1 million, and $2.6 million for Q4 2025, Q4 2024, and Q4 2023 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 200.51 Bn 194.91 Bn 7.27 Bn -
2 Stryker 129.96 Bn 126.48 Bn 4.50 Bn -
3 Medtronic 120.18 Bn 110.96 Bn 6.41 Bn -
4 Boston Scientific 74.28 Bn 73.74 Bn 3.85 Bn -
5 Edwards Lifesciences 52.75 Bn 48.50 Bn 1.35 Bn -
6 Dexcom 34.67 Bn 32.73 Bn 830.00 Mn -
7 GE HealthCare Technologies 34.23 Bn 32.12 Bn 2.18 Bn -
8 Koninklijke Philips 26.46 Bn 23.14 Bn 4.55 Bn 539.34 Mn
9 Steris 23.30 Bn 22.82 Bn 684.20 Mn -
10 Alphatec Holdings 1.48 Bn 1.36 Bn 154.10 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 2.18 Mn
Dec 31, 2024 3.13 Mn
Dec 31, 2023 2.60 Mn
Dec 31, 2022 3.00 Mn
Dec 31, 2021 2.90 Mn
Sep 30, 2021 2.71 Mn